Industry News
TGA streamlines adverse event reporting
AusBiotech has welcomed the TGA's announcement that it has introduced a streamlined way for sponsors to submit adverse event reports for medicines and vaccines, to ease the administrative burden of the 7000-8000 annual reports. [ + ]
Mesoblast MPCs improve function in heart failure
During a recent trial, heart failure patients on assisted circular support demonstrated improved cardiac function when injected with Mesoblast (ASX:MSB) MPCs at time of LVAD implantation. [ + ]
Supporting Indigenous health and wellbeing
A philanthropic donation of $10 million for Indigenous health has been gifted to the University of Western Australia. [ + ]
To clump or not to clump
A new technique that can distinguish between closely related strains of bacteria could lead to improved infection diagnosis. [ + ]
Crowd funding to fight melioidosis
Researchers from James Cook University (JCU), who recently developed a highly sensitive and rapid multiplex diagnostic test for melioidosis, have launched a crowd funding campaign to help make their test a reality. [ + ]
Director of Australian Synchrotron announced
The Synchrotron Light Source Australia (SLSA) Board today announced the appointment of Professor Andrew Peele as Director of the Australian Synchrotron. Professor Peele has held the role on an interim basis since the beginning of 2013, overseeing the day-to-day delivery of world-class science at the facility. [ + ]
NMI Prize for 2013 awarded
Physicist Dr Daniel Creedon was yesterday awarded the prestigious federal government National Measurement Institute (NMI) Prize at a ceremony in Sydney, where he gave a seminar on his award-winning work. Dr Creedon was announced as the winner of the prize on World Metrology Day earlier this year. [ + ]
Patrys wins new Aussie patent for cancer antibody
Patrys has been granted a second Australian patent - its seventh globally - covering anticancer antibody PAT-SM6. [ + ]
Government to cut R&D incentive for big business
The government plans to remove access to the R&D tax incentive for big business. [ + ]
Quarterly payments of R&D tax incentive stalled in review
AusBiotech is urging the Coalition government to deliver on its pro-business rhetoric and pass the R&D Tax Incentive's quarterly payments legislation. The much-anticipated measure has been earmarked as "further consultation required" in Treasurer Joe Hockey's plan to deal with the backlog of unlegislated tax measures: 'Restoring Integrity in the Australian Tax System'. [ + ]
IDT breaks into generic drugs with US filing
Pharmaceutical manufacturing company IDT Australia (ASX:IDT) has filed the first of a series of planned marketing applications for generic drugs, with a US filing for chemotherapy temozolomide. [ + ]
Appetite for protein drives overeating
The overriding drive for protein in our diet could play a key role in the global obesity epidemic. [ + ]
The most powerful X-ray machine ever developed
Scientists at the University of Melbourne's School of Physics have built a rotating anode source that turns ordinary X-rays into super X-rays, thus developing the world's most powerful X-ray machine. [ + ]
Novogen, Genea testing drugs for genetic diseases
Novogen (ASX:NRT) has teamed with Genea biocells to test a line of compounds which are effective against cancer stem cells in a range of genetic and degenerative disorders. [ + ]
Call for applications for sugar cane industry scholarships
Applications are open for funding and postgraduate scholarships from Sugar Research Australia (SRA) to conduct research that supports the Australian sugar cane industry. [ + ]